| Bioactivity | Lp-PLA2-IN-9 (compound 17), a tetracyclic pyrimidinone compound, is a potent Lp-PLA2 inhibitor with a pIC50 of 10.1 for rhLp-PLA2. Lp-PLA2-IN-9 has the potential for neurodegenerative related diseases research[1]. |
| Name | Lp-PLA2-IN-9 |
| CAS | 2637485-12-0 |
| Formula | C25H19ClF5N3O4 |
| Molar Mass | 555.88 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Qiong Xiao, et al. Tetracyclic pyrimidinone compounds, preparation method, composition and application thereof. CN112574221B. |
Lp-PLA2-IN-9
CAS: 2637485-12-0 F: C25H19ClF5N3O4 W: 555.88
Lp-PLA2-IN-9 (compound 17), a tetracyclic pyrimidinone compound, is a potent Lp-PLA2 inhibitor with a pIC50 of 10.1 for
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.